Serum and Salivary Levels of Phosphate in Gastric and Colorectal Cancer Patients

胃癌和结直肠癌患者血清和唾液中磷酸盐水平

阅读:1

Abstract

OBJECTIVE: Gastrointestinal cancer is one of the most common causes of death worldwide. As there are no clinical symptoms at the beginning of the disease, the diagnosis can be delayed and the stage increased. Timely diagnosis is therefore crucial. Since one of the factors involved in cell division is phosphate, and considering the benefits of using saliva, this study investigated the phosphate concentration in saliva and serum in patients with gastric and colorectal cancer as well as in healthy patients. METHODS: 26 patients with gastric and colorectal cancer confirmed by pathologic criteria were admitted to the oncology department of Imam Reza Hospital, and 30 healthy individuals participated in this study. Saliva and serum samples were collected in the morning. Phosphate concentration was determined using a photometric method. RESULTS: The average phosphate content in serum as well as in stimulated and unstimulated saliva was significantly lower in the patient group. In addition, the results showed that the patients reported more dry mouth than the control group despite increased salivary flow. CONCLUSION: It appears that patients with malignant diseases of the gastrointestinal tract, such as colorectal cancer and gastric cancer, have lower serum and salivary phosphate levels than healthy individuals.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。